Endo International (ENDP)

Add to Watchlists
Create an Alert
57.26 -0.44  -0.76% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
ENDP Price Chart
View All Events

ENDP Events

Date Type Description
Feb 28 Misc Endo Health Solutions Inc Q4 2013 Earning Conference Call
Feb 28 Earnings Endo Health Solutions Inc Q4 2013 Earning Result. Estimate: 0.94.
Feb 28 Misc Endo Completes Acquisition of Paladin Labs
Feb 26 Misc SGM Event for Endo Health Solutions Inc
Feb 03 Misc Endo Completes Acquisition of Specialty Generics Company Boca Pharmacal
Nov 07 Misc Q3 2013 Endo Health Solutions Inc. Earnings Conference Call
Nov 07 Earnings Endo to Announce Third Quarter 2013 Financial Results on November 7, 2013. Estimate: 1.12.
Nov 05 Misc Endo to Acquire Specialty Pharmaceutical Company Paladin Labs
Aug 28 Misc Endo to Acquire Specialty Generics Company Boca Pharmacal
Aug 06 Misc Q2 2013 Endo Health Solutions Inc. Earnings Conference Call
View All Performance Charts

ENDP Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Endo International is up 64.28% over the last year vs S&P 500 Total Return up 20.96%, Actelion up 66.30%, and BioDelivery Sciences up 48.40%.

Get Quote for

PDF Report for ENDP

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ENDP Pro Report PDF

Portfolio Strategies Featuring ENDP

Did Endo International make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ENDP Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: Ireland
  • Headquarters State/Province: N/A
  • Incorporation Country: Ireland
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company, focused on high-value branded products and specialty generics. Endo was established in 1997 through a management buyout from DuPont Merck. The company is based in Chadds Ford, Pennsylvania and employs more than 1,900 employees throughout the U.S.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ENDP 57.26 -0.44 -0.76% 6.621B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.